Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| +0.88% | +3.84% | +77.96% | +129.75% | 1,109B | |
| +1.07% | +3.11% | +51.11% | +56.67% | 644B | |
| +1.20% | +5.64% | +26.68% | +76.48% | 463B | |
| +1.02% | +3.67% | +43.14% | +47.27% | 371B | |
| +0.85% | +2.97% | +24.48% | +42.54% | 301B | |
| +1.26% | +4.54% | +2.20% | +14.84% | 256B | |
| +1.88% | +5.14% | +48.20% | +67.80% | 234B | |
| +1.59% | +0.87% | -12.95% | -51.91% | 205B | |
| +1.87% | +5.78% | +23.07% | +92.57% | 178B | |
| Average | -4.05% | +3.00% | +31.54% | +52.89% | 417.9B | |
| Weighted average by Cap. | +0.73% | +3.26% | +44.79% | +72.24% |
Employees
4
Sector
Pharmaceuticals
